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Embryonic stem (ES) cell self-renewal efﬁciency is deter-
mined by the Nanog protein level. However, the protein
partners of Nanog that function to direct self-renewal are
unclear. Here, we identify a Nanog interactome of over
130 proteins including transcription factors, chromatin
modifying complexes, phosphorylation and ubiquitination
enzymes, basal transcriptional machinery members, and
RNA processing factors. Sox2 was identiﬁed as a robust
interacting partner of Nanog. The puriﬁed Nanog–Sox2
complex identiﬁed a DNA recognition sequence present in
multiple overlapping Nanog/Sox2 ChIP-Seq data sets. The
Nanog tryptophan repeat region is necessary and sufﬁcient
for interaction with Sox2, with tryptophan residues
required. In Sox2, tyrosine to alanine mutations within a
triple-repeat motif (S X T/S Y) abrogates the Nanog–Sox2
interaction, alters expression of genes associated with the
Nanog-Sox2 cognate sequence, and reduces the ability of
Sox2 to rescue ES cell differentiation induced by endogen-
ous Sox2 deletion. Substitution of the tyrosines with
phenylalanine rescues both the Sox2–Nanog interaction
and efﬁcient self-renewal. These results suggest that aro-
matic stacking of Nanog tryptophans and Sox2 tyrosines
mediates an interaction central to ES cell self-renewal.
The EMBO Journal (2013) 32, 2231–2247. doi:10.1038/
emboj.2013.161; Published online 26 July 2013
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Introduction
Embryonic stem (ES) cell self-renewal efﬁciency depends on
the level of expression of components of the pluripotency
gene regulatory network. Among these, Oct4, Sox2 and
Nanog play central roles. While the levels of Oct4 and Sox2
are relatively uniform in undifferentiated ES cells, the levels
of Nanog vary considerably (Hatano et al, 2005; Chambers
et al, 2007; Singh et al, 2007) with high levels of Nanog
directing efﬁcient self-renewal (Chambers et al, 2003, 2007).
However, the mechanisms by which Nanog delivers this
function in ES cells are not fully understood. In particular,
although Nanog has been reported to interact with several
proteins (Wang et al, 2006; Wu et al, 2006; Liang et al, 2008;
Costa et al, 2013), the full extent of the Nanog interactome is
not known.
In the past few years, proteomic approaches have been
employed to characterize and begin to understand the net-
work of biochemical interactions controlling pluripotent cell
function. This has resulted in the identiﬁcation of additional
proteins that interact with the key transcriptional factors
Nanog, Sox2 and Oct4 to control and maintain the pluripotent
state. Pioneering studies by Wang et al (2006) identiﬁed a
Nanog-centred interactome of 17 proteins that extended to
other transcription factors including Oct4, Zfp281, Nac1, Rex1
and Nr0b1. This list of Nanog-interacting proteins has since
been extended (Liang et al, 2008) with a recent interactome
identifying a total of 27 Nanog interactors (Costa et al, 2013).
This relatively small number is in contrast to the larger
number of interactors identiﬁed in recent Oct4 (Pardo et al,
2010; van den Berg et al, 2010; Ding et al, 2012) and Sox2
(Gao et al, 2012) interactomes. Interactome studies have the
potential to contribute to the elucidation of the mechanisms
by which speciﬁc factors function. Central to this is the
identiﬁcation of the interacting amino-acid side chains on
partner proteins as well as the functional signiﬁcance of their
association. To date, biochemical characterization of protein–
protein interactions in pluripotent cells has been relatively
sparse with most effort analysing the interaction between
Sox2 and Oct4 (Yuan et al, 1995; Ambrosetti et al, 1997, 2000;
Remenyi et al, 2003; Kim et al, 2008; Chen et al, 2008a; Lam
et al, 2012). From a biochemical perspective, little is known
about how Nanog ﬁts into the tight relationship between Oct4
and Sox2.
Previously, we described a method to identify partner
proteins interacting with nuclear proteins of interest in ES
cells and used this to identify an extensive interaction net-
work for the transcription factor Oct4 (van den Berg et al,
2010). Here, this technique is applied to Nanog, resulting
in identiﬁcation of a Nanog interactome which includes
over 130 Nanog partners in ES cells. From this, the direct
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interaction between Nanog and Sox2 was selected for further
characterization, pinpointing individual residues required
for the interaction and deﬁning the functional consequences
of elimination of the interaction between these central
pluripotency regulators.
Results
Identiﬁcation of a Nanog interactome
An ES cell line expressing epitope-tagged Nanog protein was
obtained by transfection of E14Tg2a cells with a construct in
which the constitutive CAG promoter directs expression of
(FLAG)3Nanog, linked via an IRES to puromycin resistance.
Puromycin-resistant colonies were expanded and the
resulting cell lines were analysed by immunoblotting. A cell
line was identiﬁed (hereafter called F-Nanog) that expressed
(FLAG)3Nanog at close to endogenous levels (Figure 1A). A
qRT-PCR analysis of F-Nanog and E14Tg2a wild-type cells
showed no signiﬁcant difference in the expression level of the
ES cell-speciﬁc genes Oct4, Sox2 and Rex1 (Figure 1B). In
agreement with recent reports of autorepression by Nanog
(Fidalgo et al, 2012; Navarro et al, 2012b), F-Nanog cells
Figure 1 Characterization of E14Tg2a Flag Nanog cell line. (A) Expression levels of Nanog protein in E14Tg2a and E14Tg2a F-Nanog cells
compared by immunoblot analysis using b-actin as a loading control. Note the reduced expression of endogenous Nanog protein in cells
transfected with (Flag)3Nanog, consistent with autorepression of the Nanog gene by Nanog protein (Navarro et al, 2012a). (B) Expression levels
of Sox2, Oct4 and Rex1 in E14Tg2a F-Nanog relative to E14Tg2a which was set to 1. Error bars are s.e.m. of three biological replicates.
(C) Coomassie-stained SDS–polyacrylamide gel of the FLAG immunoprecipitation from E14Tg2a F-Nanog and control E14Tg2a cells.
(D) Proteins detected by mass spectrometry analysis are grouped in classes. Transcription factors are shown in blue circles, NuRD components
are in green, Trrap/p400 complex is in yellow, PcG components are in red, E2F6 complex is in purple, Sin3a complex is in burgundy, N-CoR
complex is in khaki, LSD1 complex is white, Mll complex is in blue green, chromatin remodelling/transcriptional regulation proteins are in dark
orange, transcriptional machinery proteins are in pale green, proteins involved in phosphorylation are in pale blue, proteins involved in
ubiquitination are in amber, proteins involved in RNA processing are in fuschia, proteins involved in cell cycle or DNA replication are in coral,
proteins involved in DNA repair are in pink and other proteins are in grey. (E) Nuclear extracts from E14Tg2a F-Nanog cells (top) or from RCNbH-
B(t):F-Nanog (bottom) were immunoprecipitated as indicated and immunoblots analysed with the indicated antibodies. In the bottom panel, C
refers to control samples from RCNbH-B(t) parental cells. Source data for this ﬁgure is available on the online supplementary information page.
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show a strong decrease in expression of endogenous Nanog,
which has the fortuitous consequence of maximizing the
proportion of Nanog protein immunoprecipitated by anti-
FLAG reagents.
Nuclear extracts were prepared from F-Nanog cells and
parental E14Tg2a cells and used for FLAG-afﬁnity puriﬁca-
tions as previously described (van den Berg et al, 2010). A
Coomassie-stained gel of the eluted fractions showed several
bands absent from the control E14Tg2a sample, indicating
good signal-to-background ratio (Figure 1C). Mass spectro-
metry analysis was then performed on two independent
afﬁnity puriﬁcations from both F-Nanog and E14Tg2a control
cells. An extensive set of Nanog partners was identiﬁed that
could be grouped into several functional categories (Table I;
Supplementary Table I; Figure 1D). The group with the
highest representation is transcription factors, other groups
present being chromatin modiﬁcation complexes (e.g., NuRD
and NcoR), proteins involved in phosphorylation or ubiqui-
tination, basal transcriptional machinery members and
RNA processing proteins. Mass spectrometric analysis
of an independent cell line generated by expressing the
same (Flag)3Nanog expression cassette in a Nanog-null
ES cell line (RCNbH-B(t)) (Chambers et al, 2007) was used
to verify candidate Nanog-interacting proteins (Table I;
Supplementary Table I). Only the proteins identiﬁed in two
out of three puriﬁcations are included in Table I and
Supplementary Table I. Interactions between Nanog and
Sox2, RNA polymerase II (RNAPolII), Nac-1, Sall4 and the
NuRD subunit Mta2 were also observed by immunoblotting
(Figure 1E). The Nanog interactome substantially overlaps
with the published interactome of Oct4, Esrrb, Sall4, Nr0b1
and Tcfcp2l1 (van den Berg et al, 2010) (Figure 2).
Interestingly, Chd7 and the Ncor1 complex, which are not
part of the Oct4/Esrrb/Sall4/Nr0b1/Tcfcp2l1 interactome,
do interact with Nanog (Figure 2). This may reﬂect the robust
interaction of Nanog with Sox2 (Table I; Supplementary
Table I) as both Chd7 and the Ncor1 complex interact with
Sox2 (Engelen et al, 2011).
Mapping the domain of Nanog interacting with Sox2
Due to the key role of Sox2 in ES cell biology, further
characterization of the interaction between Nanog and Sox2
was undertaken. To determine whether the interaction be-
tween Nanog and Sox2 could be detected in wild-type ES
cells, E14Tg2a nuclear extract was incubated either with an
anti-Sox2 antibody and immunoprecipitates examined for the
presence of Nanog or with an anti-Nanog antibody and
immunoprecipitates examined for Sox2. Nanog was detected
in Sox2 immunoprecipitates (Figure 3A) and Sox2 was also
detected in Nanog immunoprecipitates (Figure 3B). To map
the sites of interaction, co-transfections of (Flag)3Sox2 with
(HA)3Nanog or Nanog deletion mutants were performed
(Figure 3C) in E14/T cells (Chambers et al, 2003). Nuclear
extracts from ES cells transfected with (HA)3Nanog and
(HA)3-tagged mutants lacking the N-terminus, the DNA
binding homeodomain (HD) or the C-terminus of Nanog
were immunoprecipitated with the HA antibody and after
SDS–PAGE, immunoblots were probed for the presence of
interacting Sox2 using a Flag antibody. (Flag)3Sox2 does not
interact with a Nanog mutant lacking the C-terminal domain
but the interaction between Sox2 and Nanog variants lacking
either the N-terminus or the HD remained intact (Figure 3C).
To identify the subregion of the Nanog C-terminal domain
responsible for the interaction with Sox2, (Flag)3Sox2 was co-
transfected with (HA)3Nanog variants carrying mutations
within the C-terminal domain. Co-immunoprecipitations
showed that deletion of the tryptophan repeat (WR) region,
within the C-terminal domain of Nanog, but not residues
C-terminal to the WR, abrogated the interaction with Sox2
(Figure 3D). Importantly, a Nanog mutant in which all 10
tryptophan residues in the WR region were mutated to
alanines, (HA)3Nanog WRW10-A, also failed to interact with
Sox2, pinpointing the tryptophan residues as critical determi-
nants of the interaction with Sox2. To determine whether the
interaction of Nanog and Sox2 was direct, Sox2 was co-
expressed in E. coli alongside a fusion between Maltose
Binding Protein and, either the Nanog tryptophan repeat, or
the Nanog tryptophan repeat in which all the tryptophans
were replaced by alanines (MBP-WR or MBP-WRW10-A)
(Figure 3E). The MBP-fusion proteins were then puriﬁed on
an amylose column and any interacting Sox2 was detected by
immunoblotting with a Sox2 antibody. Only MBP-WR but not
MBP-WRW10-A was able to co-precipitate Sox2 (Figure 3E).
Taken together, these experiments indicate that Nanog
and Sox2 interact directly, that the interaction with Sox2
can be mediated by the Nanog WR domain alone and that
tryptophan residues within the WR are required for
interaction with Sox2. In addition, the ability of these pro-
teins to interact in E. coli implies that post-translational
modiﬁcations are not required for interaction between
Nanog and Sox2.
The region of Sox2 interacting with Nanog
To identify the region of Sox2 involved in the interaction with
Nanog, we investigated mutants carrying deletions within the
C-terminal domain, the HMG DNA binding domain or resi-
dues at the N-terminus of Sox2 (Figure 4A). Each of these
mutants was co-expressed with (HA)3Nanog in E14/T cells,
nuclear extracts prepared and the HA antibody used to co-
immunoprecipitate (HA)3Nanog and interacting proteins.
Samples were then analysed by SDS–PAGE and immuno-
blotting. (Flag)3Sox2 mutants lacking the N-terminal region,
the DNA binding domain or the C-terminal 56 amino acid
residues [(Flag)3Sox2 1-263] were still able to interact with
Nanog (Figure 4A). However, (Flag)3Sox2 1-204 does not
interact with Nanog, suggesting that the serine-rich region
is involved in the interaction with the Nanog WR.
The persistence of the Nanog–Sox2 interaction in nuclear
extracts that have been treated with the nuclease, benzonase,
to eliminate interactions mediated via DNA bridging, sug-
gests that DNA binding is not required for the Nanog–Sox2
interaction. Moreover, the above results indicate that Nanog
and Sox2 can interact in the absence of a DNA binding
domain on either of the proteins (Figures 3C and 4A). To
consolidate the notion that Nanog–Sox2 interaction is fully
DNA independent, we show by co-immunoprecipitation of
(Flag)3Sox2DHMG and (HA)3NanogDHD that Nanog and
Sox2 molecules that lack the DNA binding domains can still
interact (Figure 4B).
Our analysis of the ability of (HA)3Nanog to co-immuno-
precipitate Sox2 mutants (Figure 4) suggested that the serine-
rich region, from residues 205 to 263, plays a key role in the
Nanog interaction. To narrow down the region of Sox2
interacting with Nanog, further deletion mutants within this
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Table I Nanog-interacting proteins as identiﬁed by mass spectrometry analysis of puriﬁed Nanog samples
E14Tg2a F-Nanog
#1
E14Tg2a F-Nanog
#2
RCNbH-B(t) F-Nanog
#1
Protein Accession Mascota Peptidesb Mascota Peptidesb Mascota Peptidesb Average
Mascot
Nanog Q80Z64 445 7 339 5 406 7 397
Transcription factors
Sall4 Q8BX22 1880 (425) 26 (8) 1818 (391) 28 (9) 2398 (918) 35 (19) 2032
Bptf A2A654 2402 38 1804 42 362 9 1523
Sall1 Q6P5E3 1306 20 1447 25 1696 (185) 30 (3) 1483
Smarca5 Q91ZW3 1453 (721) 25 (15) 1099 (364) 26 (12) 506 11 1019
Esrrb E9QKA2 841 (88) 13 (2) 663 12 860 (52) 15 (1) 788
Zfp462 B1AWL2 811 18 470 11 1067 26 783
Zfp281 Q99LI5 753 12 751 16 759 14 754
Nr0b1 Q61066 729 9 761 12 647 12 712
Myef2 Q99N20 519 (424) 9 (8) 726 (217) 12 (4) 726 (133) 14 (3) 657
Arid3b Q99LI5 490 (85) 6 (1) 719 12 435 9 548
Nac1 Q7TSZ8 601 (75) 10 (1) 610 (80) 13 (2) 898 15 527
Zfp219 Q6IQX8 637 11 580 11 548 11 441
Arid5b Q8BM75 547 10 622 13 117 2 429
Sall3 Q62255 336 5 312 5 583 11 410
Bnc2 E9Q5T4 271 5 354 9 431 9 352
Zfp609 E9Q1Y2 380 7 467 9 511 10 340
Ubtf P25976 566 (101) 12 (2) 223 5 60 2 283
Sox2 Q60I23 264 5 250 4 307 5 274
Rex1 P22227 209 (47) 3 (1) 65 1 541 (130) 9 (3) 272
Rex2 Q6NWW4 303 (66) 4 (2) 208 4 199 4 237
Klf5 Q9Z0Z7 168 3 88 2 418 (71) 9 (2) 225
Zbtb2 Q3V3W4 125 2 200 4 275 (52) 5 (1) 200
Cxxc5 Q91WA4 148 3 216 4 213 5 192
Zfp326 O88291 330 5 366 7 64 1 190
Fiz1 Q9WTJ4 233 (74) 4 (2) 125 (79) 2 (2) 201 3 186
Zfp278 Q80XS2 204 4 272 8 75 2 184
Zbtb34 A2ATY4 118 1 42 1 227 4 173
Zic3 Q62521 249 4 116 3 105 2 157
Brms1 Q99N20 221 4 62 1 118 3 134
Grhl2 Q8K5C0 88 2 127 3 — — 72
NuRD complex
Chd4 Q6PDQ2 2847 (560) 55 (13) 1917 (160) 44 (5) 942 22 1902
Gatad2a Q8CHY6 938 (50) 17 (1) 1331 (128) 21 (3) 1566 (244) 25 (5) 1278
Mta1 F8WHY8 988 (272) 17 (4) 1220 (355) 17 (8) 726 14 978
Gatad2b Q8VHR5 692 (170) 10 (3) 950 (141) 17 (3) 1183 (472) 19 (9) 942
Mta2 Q9R190 775 (154) 12 (5) 1201 (150) 22 (4) 796 17 924
Mta3 E9Q794 715 (245) 12 (4) 820 16 675 12 737
Mbd3 D3YTR4 746 (155) 12 (3) 469 (96) 7 (3) 777 (264) 13 (5) 664
Mbd2 Q9Z2E1 50 2 95 3 152 4 99
Trrap/p400 complex
Trrap E9QLK7 2434 (565) 48 (14) 1067 (84) 26 (2) 1241 29 1581
Ep400 Q8CHI8 898 (45) 17 (2) 483 14 695 15 797
Yeats4 Q9CR11 435 9 261 6 114 3 270
Dmap1 Q9JI44 224 (114) 2 (1) 328 (68) 7 (2) 235 4 262
Vps72 Q62481 142 3 73 2 116 3 110
Brd8 D3YZC7 117 2 — — 192 3 103
Polycomb complex
Mbtd1 Q6P5G3 136 3 166 3 197 3 166
Phc1 Q64028 537 10 486 9 415 8 479
Rnf2 Q9CQJ4 446 9 311 7 312 (155) 5 (3) 356
Rybp Q8CCI5 277 (395) 4 (5) 163 3 383 (54) 6 (1) 274
Ezh2 E9QNF8 94 1 — — 212 5 102
Pcgf6 Q99NA9 115 2 — — 163 4 93
E2F6 complex
Mga E9QLG3 817 13 752 18 395 9 655
Cbx3 P23198 499 (367) 6 (5) 282 (75) 4 (2) 358 (83) 6 (2) 380
Rnf2 Q9CQJ4 446 9 311 7 312 (155) 5 (3) 356
Ehmt1 Q5DW34 229 5 111 3 429 9 256
Ehmt2 Q9Z148 — — 57 2 491 12 183
L3mbtl2 P59178 161 (47) 3 (1) 242 (41) 6 (1) 101 1 168
Max P28574 122 2 158 3 — — 93
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Table I Continued
E14Tg2a F-Nanog
#1
E14Tg2a F-Nanog
#2
RCNbH-B(t) F-Nanog
#1
Sin3a complex
Sin3a Q60520 1123 (154) 19 (3) 765 (143) 16 (5) 1221 (223) 22 (6) 1036
Hcfc1 Q61191 546 (291) 9 (7) 419 (114) 12 (3) 926 20 630
Ncor1 E9Q2B2 237 4 358 7 254 5 283
Sap130 Q8BIH0 144 3 69 2 220 4 144
Mbd2 Q9Z2E1 50 2 95 3 152 4 99
N-CoR complex
Tbl1xr1 Q8BHJ5 962 (289) 13 (5) 837 (236) 13 (4) 292 5 697
Tbl1x Q9QXE7 677 10 663 12 479 8 606
Ncor1 E9Q2B2 237 4 358 7 254 5 283
Hdac3 Q3UM33 226 6 250 5 69 2 182
LSD1 complex
Lsd1 Q6ZQ88 589 (237) 12 (4) 647 (106) 12 (3) 924 (58) 17 (2) 720
Zmym2 Q9CU65 155 2 281 6 1005 21 480
Rcor1 E9QK09 68 1 — — 91 2 53
MLL complex
Hcfc1 Q61191 546 (291) 9 (7) 419 (114) 12 (3) 926 20 630
Bap18 Q9DCT6 663 (47) 14 (1) 933 19 222 4 606
Mll2 O08550 668 16 195 7 133 3 332
Mll3 Q8BRH4 670 14 259 8 — — 310
Ash2l E9PU93 174 4 340 7 273 6 204
Men1 O88559 68 2 125 3 245 4 146
Myst1 Q9D1P2 131 3 100 3 205 4 145
Rbbp5 Q8BX09 114 3 219 6 76 2 63
Chromatin remodelling/transcriptional regulation
Chd7 A2AJK6 1408 (154) 24 (4) 944 17 252 7 868
Cnot1 Q6ZQ08 1471 (355) 33 (9) 710 (221) 18 (6) 245 (62) 6 (2) 809
Tet 1 E9Q9Y4 1370 24 — — 390 9 587
Arid1a E9QAQ7 83 3 182 5 1315 (179) 27 (4) 527
Rcor2 Q8C796 240 (99) 4 (2) 423 (48) 7 (1) 694 12 452
Morf4l1 P60762 458 (47) 8 (1) 446 10 367 7 424
Wiz F6ZBR8 247 4 185 4 769 17 400
Bcor Q8CGN4 322 7 454 11 279 6 352
Hira Q61666 451 7 394 11 102 3 316
Hist1h1c P15864 274 4 139 3 112 2 175
Transcriptional machinery
Ints1 Q6P4S8 721 (172) 14 (5) 608 (213) 13 (6) 248 6 526
Wdr82 Q8BFQ4 592 (431) 9 (8) 320 (69) 8 (2) 377 (78) 8 (1) 430
Supt6h Q62383 868 18 252 7 101 3 407
Polr2a P08775 240 (93) 2 148 4 481 11 290
Taf9 Q8VI33 317 7 158 4 261 7 245
Polr2b Q8CFI7 281 5 122 3 — — 134
Phosphorylation
Akap8 Q9DBR0 827 (190) 14 (3) 760 (162) 13 (3) 859 (75) 15 (1) 815
Csnk2a Q60737 408 (118) 8 (3) 323 (45) 7 (2) 431 8 387
Csnk1a1 E9Q2U6 247 5 202 5 151 4 200
Ppp2r1a Q76MZ3 178 (67) 4 (2) 261 6 57 2 165
Ubiquitination
Uchl5 Q9WUP7 349 (101) 6 (2) 344 (96) 8 (2) 238 (88) 5 (2) 310
Stub1 Q9WUD1 457 10 350 7 83 2 297
Ranbp2 Q9ERU9 283 (90) 8 (2) 164 (44) 4 (1) 932 (42) 20 (3) 220
RanGAP1 E9Q757 118 (47) 3 (1) 289 6 370 (85) 7 (2) 164
Psmd11 Q8BG32 217 (70) 6 (2) 137 (43) 4 (2) — — 118
RNA processing
Hnrnph2 P70333 513 8 625 (174) 11 (5) 545 10 2437
Dhx9 O70133 972 17 502 12 1126 (530) 22 (13) 867
Ilf3 Q45VK5 1388 (689) 22 (14) 1022 (230) 21 (7) 670 13 803
Raly Q3U3F6 480 (488) 9 (10) 392 (119) 7 (3) 271 7 381
Zcchc8 Q9CYA6 425 5 377 6 274 5 359
Ddx1 Q91VR5 167 (354) 4 (8) 333 (63) 7 (2) 259 6 253
Wdr33 Q8K4P0 316 (42) 6 (1) 221 (77) 6 (3) 219 6 252
Pum1 Q80U78 274 (120) 6 (3) 290 (66) 7 (2) 177 4 247
Rbm9 Q8BP71 214 4 305 4 210 4 243
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region were generated (Figure 5A). Co-immunoprecipitation
analyses show that while a Sox2 mutant truncated after
residue 233 retained the ability to interact with Nanog,
Sox2 mutants with deletion of residues between 205 and
233, or truncated after residue 212 were unable to interact
with Nanog (Figure 5B). These analyses identify a critical
Nanog-interacting region in Sox2 between residues 212 and
233. This sequence is highly enriched for hydroxyamino acids
(12/21 residues) and, like the WR of Nanog, is devoid of
acidic and basic side chains. Moreover, careful examination
of this 21 amino-acid region highlighted three repeats of the
sequence S X T/S Y that may be responsible for mediating
the interaction with Nanog. To determine the potential im-
portance of these motifs for the Nanog–Sox2 interaction,
additional truncations were made after residues 218 and
226, which truncate Sox2 after repeat 1 or 2, respectively.
This indicates that repeat 1 is sufﬁcient for interaction with
Nanog but that together repeats 1 and 2 interact with Nanog
with an efﬁciency approaching that of wild-type Sox2
(Figure 5B). To examine the sequences required on Sox2 in
more detail, a series of point mutations were generated
within the repeats (Figure 6). Individual or combinatorial
contributions of each of the three repeats to Nanog binding
were initially examined (Figure 6A and B). Mutation of
individual repeats suggests an order of importance for
Nanog interaction of repeat 14repeat 34repeat 2
(Figure 6A). This is supported by analyses of the combina-
torial mutants where mutation of repeats 1þ 3 almost
entirely eliminates the ability of Sox2 to interact with
Nanog (Figure 6B). Mutations of the amino acids at positions
1, 3 or 4 in all the three repeats were next analysed.
Combined mutations at positions 1 and 3 had negligible
effects (Figure 6C), implying that residues at these positions
are not required for Nanog interaction. In contrast, the
combined mutation of the tyrosines at position 4 indicates
that these residues play a key role in the interaction with
Nanog (Figure 6C). Together, these experiments suggest that
the tyrosines are the residues directly interacting with the
Nanog WR, with the tyrosines in repeats 1 and 3 being more
important in this regard than the tyrosine in repeat 2.
The Sox2 tyrosine residues could interact with Nanog
partially via the hydroxyl, the phenyl ring or both. Since
Table I Continued
E14Tg2a F-Nanog
#1
E14Tg2a F-Nanog
#2
RCNbH-B(t) F-Nanog
#1
Mtr3 Q8BTW3 380 (74) 5 (1) 120 (108) 2 (2) 212 4 237
Mov10 P23249 251 (45) 6 (1) 185 (58) 3 (2) — — 145
Rbm4b Q8VE92 87 2 61 2 279 6 142
Ints4 Q8CIM8 112 3 122 3 192 4 142
Pum2 Q80U58 122 2 187 4 — — 103
Cell cycle/DNA replication
Sgol2 Q7TSY8 747 (91) 12 (3) 387 (52) 8 (2) 735 13 623
Mad1l1 Q9WTX8 493 (126) 9 (3) 520 11 732 (984) 14 (20) 582
Rfc4 Q99J62 517 (171) 13 (5) 541 (265) 10 (7) 324 (78) 6 (2) 461
Gtse1 Q8R080 635 (178) 9 (3) 587 11 64 1 429
Tpx2 A2APB8 374 (40) 8 (1) 142 3 383 9 300
Orc5l Q9WUV0 196 (45) 4 (1) 109 (140) 3 (4) 260 5 188
Smc3 Q9CW03 124 3 — — 338 9 154
Mat89Bb Q8QZV7 125 (30) 3 (1) 144 5 184 4 151
Pogz D3YUW8 91 1 40 1 268 6 180
DNA repair
Msh6 P54276 613 (112) 15 (3) 623 (139) 14 (4) 208 6 481
Brca2 P97929 576 14 309 9 296 9 394
Rad51 D6RCK1 328 5 208 4 232 5 256
Brca1 A2A4Q4 74 2 157 4 466 12 239
Emsy Q8BMB0 306 (52) 6 (2) 149 5 69 2 152
Other
Sec16 E9QAT4 889 (44) 15 (1) 777 18 353 8 673
Cad O54788 883 18 968 24 108 1 653
Qser1 A2BIE1 669 (192) 11 (4) 433 9 826 16 643
Zfr O88532 241 (80) 4 (1) 193 (67) 4 (1) 1155 21 530
Dnaja1 P63037 515 (144) 9 (2) 345 (107) 8 (2) 514 8 458
2810474O19RIK D3Z687 633 (47) 14 (1) 933 19 — — 380
C130039O16Rik E9Q2I4 474 (41) 7 (1) 314 7 258 5 349
Skt A2AQ25 247 5 665 15 60 2 324
Wdr68 P61963 385 5 381 8 168 4 311
Dnttip1 Q99LB0 442 (37) 8 (1) 167 3 177 3 262
Sec13 Q9D1M0 498 (58) 7 (1) 207 5 76 2 260
Kpna2 P52293 292 (90) 5 (1) 260 5 226 3 259
Dpf2 Q61103 244 3 145 3 375 (148) 8 (4) 255
a
Mascot score for the speciﬁed protein in the Nanog sample, puriﬁed by FLAG afﬁnity. Mascot score for the speciﬁed protein in the
corresponding control puriﬁcation, if present, is in parentheses.
b
Number of identiﬁed unique, nonredundant peptides for the speciﬁed protein in the Nanog sample. Number of identiﬁed unique peptides in
the control puriﬁcation is in parentheses.
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the tryptophans in WR are critical for the Nanog/Sox2
interaction this raises the hypothesis that hydrophobic stacking
of the aromatic rings in the Sox2 tyrosines and the Nanog WR
tryptophans mediate the interaction. If these were the case,
then the tyrosines hydroxyl groups should be unimportant for
the interaction between Nanog and Sox2. To test this hypo-
thesis, the tyrosines were mutated to phenylalanine. The direct
comparison of the interaction between (HA)3Nanog and
(Flag)3Sox2:YYY4A or (Flag)3Sox2:YYY4F by co-immuno-
precipitations clearly shows that substitution of the tyrosine
residues with phenylalanines rescues the Nanog interaction,
indicating that it is the benzene ring of these amino-acid
residues that is required for the interaction to occur (Figure 6D).
Identiﬁcation of Nanog/Sox2 binding motif in vitro
To investigate possible DNA sequences bound by the Nanog/
Sox2 complex, (His)6-tagged Nanog and unmodiﬁed Sox2
were co-expressed in E. coli for use in Systematic Evolution
of Ligands by Exponential Enrichment (SELEX). As controls,
MBP-Nanog and (His)6-Sox2 were expressed individually.
Puriﬁcation from bacterial lysate containing co-expressed
proteins on a nickel column followed by elution with imida-
zole yielded two proteins of the expected size for Nanog and
Sox2. These were recognized by a-Nanog and a-Sox2 anti-
bodies (Figure 7A), with N-terminal sequencing establishing
the identities of the two bands as Nanog and Sox2. The
Nanog–Sox2 interaction is robust, since the proteins co-purify
through subsequent ion exchange (Figure 7B). The Nanog–
Sox2 complex bound to the Ni-agarose, MBP-Nanog bound to
amylose resin and (His)6-Sox2 bound to Ni-agarose were
used for SELEX, the bound oligonucleotides cloned and the
sequences determined (Figure 7C) used to derive the motifs
shown (Figure 7D). The motif obtained from Nanog alone has
a TAAT core sequence followed by CG, consistent with the
motif obtained previously by SELEX (Mitsui et al, 2003) and
the nucleotide preferences of the isolated Nanog HD in
EMSAs (Jauch et al, 2008). Sox2 also gives a motif highly
similar to that determined by SELEX (CA/TTTGA/T) (Harley
et al, 1994; Maruyama et al, 2005). The motif obtained from
the Nanog/Sox2 complex is bipartite with bases 10–15 similar
to the motif obtained by us and others for Sox2 alone (Harley
et al, 1994; Maruyama et al, 2005) and bases 5–7 showing
similarity to the central core of the Nanog motif identiﬁed by
SELEX (TAAT) in this work and by others (Mitsui et al, 2003).
However, the published Nanog motif has a high degree of
conﬁdence over a four base sequence (TAAT) while the
Nanog–Sox2 binding sequence shows high certainty for
only three bases (TAA) with the preference for the 30-ﬂanking
CG no longer apparent. This difference may reﬂect an altera-
tion in the binding speciﬁcity of Nanog when in complex with
Sox2. Interestingly, the SELEX motif shows high similarity to
a Nanog/Sox2 motif identiﬁed by de novo methods from
Figure 2 The Nanog interaction network. The Nanog interactome (pale blue) as part of a larger interactome encompassing the interactions of
Oct4, Esrrb, Sall4, Nr0b1 and Tcfcp2l1 (van den Berg et al, 2010).
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ChIP-Seq data (Hutchins et al, 2013), which notably also
contains a 2-bp gap between the major binding nucleotide
groups (Figure 7D). Therefore, a combined motif was gene-
rated and used to search available ChIP-Seq data sets. Analysis
of three independent ChIP-Seq data sets (Chen et al, 2008b;
Marson et al, 2008; Whyte et al, 2013) identiﬁed 3257 Nanog/
Sox2 overlapping peaks, which are common to the three data
sets (out of a total of 16 454 from all Nanog/Sox2 overlapping
peaks in the three data sets). Of these 3257 high conﬁdence
peaks, 29.1% (948 peaks) contain the motif. The motif
occurs in a signiﬁcantly smaller fraction of the Nanog only
or Sox2 only peaks (4898 peaks out of a total of 31 271 peaks
(15.7%; hypergeometric P-value o11010). Examples of
occurrences of the motif relative to the nearest gene are
shown (Figure 7E; Supplementary Table II).
The Nanog–Sox2 interaction is critical for Sox2 function
To investigate the functional signiﬁcance of the interaction
between Nanog and Sox2, we took advantage of ES cells
carrying a conditional Sox2 knock-out allele (Sox2CKO). In
this cell line, one of the Sox2 alleles is ﬂanked by loxP sites
(Favaro et al, 2009), while the other Sox2 allele has been
replaced with a b-geo cassette (Zappone et al, 2000;
Avilion et al, 2003). These cells also have a constitutively
expressed CreERT2-IRES-Puro transgene integrated randomly
in the genome. Upon addition of tamoxifen, CreERT2 is
Figure 3 Mutational analysis of the Sox2-interaction domain in Nanog. (A) Co-immunoprecipitation of endogenous Sox2 and Nanog from
E14Tg2a nuclear extract. Immunoprecipitation was performed with Sox2 antibody and immunoblot probed with anti-Nanog or anti-Sox2
antibodies. (B) Co-immunoprecipitation of endogenous Nanog and Sox2 from E14Tg2a nuclear extract. Immunoprecipitation was performed
with Nanog antibody and immunoblot probed with anti-Sox2 or anti-Nanog antibodies. (C) Left, schematic representation of the (HA)3Nanog
constructs. Right, co-immunoprecipitations of Nanog variants with Sox2. (FLAG)3Sox2 and (HA)3Nanog deletion mutants were transfected into
E14/T cells. Immunoprecipitations were performed with an HA antibody as indicated and immunoblots probed with anti-FLAG or anti-HA
antibodies. I is 1% of input. (D) Left, schematic representation of the (HA)3Nanog constructs. Right, co-immunoprecipitations of Nanog
variants with Sox2. (FLAG)3Sox2 and (HA)3Nanog deletion mutants were transfected into E14/T cells. Immunoprecipitations were performed
with an HA antibody as indicated and immunoblots probed with anti-FLAG or anti-HA antibodies. I is 1% of input. (E) Left, Sox2, co-expressed
in E. coli with either a Maltose Binding Protein-tryptophan repeat (MBP-WR) fusion protein or a Maltose Binding Protein-tryptophan repeat in
which all the tryptophans were mutated to alanine (MBP-WRW10-A). Right, MBP fusion proteins and associated proteins were puriﬁed on
amylose resin, subjected to SDS–PAGE and immunoblots probed with Sox2 or MBP antibodies. Source data for this ﬁgure is available on the
online supplementary information page.
Proteomic identiﬁcation of a Nanog–Sox2 complex
A Gagliardi et al
2238 The EMBO Journal VOL 32 | NO 16 | 2013 &2013 European Molecular Biology Organization
translocated to the nucleus and excises the Sox2 gene
between the loxP sites (Figure 8A). As ES cells from which
Sox2 activity has been removed are unable to self-renew and
differentiate into trophectoderm-like cells (Masui et al, 2007),
this cell line was used to test whether Sox2 mutant molecules
impaired in Nanog binding could rescue the Sox2 null
phenotype (Figure 8B). Sox2CKO cells expressing a GFP
control plasmid completely differentiate upon Tamoxifen
treatment (Figure 8B). As expected, cells transfected with
an unmutated (Flag)3Sox2 cDNA rescued this differentiation
phenotype. In contrast, cells expressing (Flag)3Sox2:YYY4A
transgene showed a decrease in self-renewal activity with
50% fewer undifferentiated colonies compared to wild-type
Sox2 (Figure 8C). In accordance with the interaction data,
expression of (Flag)3Sox2:YYY4F fully rescued the differen-
tiation phenotype (Figure 8C). To examine the possibility that
the reduced colony formation by the Sox2:YYY4A cells was
due to a reduced expression level, an immunoblot for Sox2
was performed. However, the amount of Sox2 expressed is
comparable between Sox2:YYY4A and other lines and does
not differ from the endogenous Sox2 level expressed by the
parental line (Figure 8D). These data suggest that the inter-
action with Nanog is a key component in the function of Sox2
in ES cell self-renewal.
To further investigate the effect of disrupting the Nanog–
Sox2 interaction, the expression of genes present in the ChIP-
Seq data sets was examined in cell lines expressing wild-type
or mutant Sox2 (YYY4A). Of 13 genes analysed, 5 showed
consistent differences by qRT-PCR when the Nanog/Sox2
complex was disrupted (Figure 8E). The genes that show
altered expression include transcription factors reported to be
important for ES cell identity (Rex1 and Klf5 (Shi et al, 2006;
Parisi et al, 2010), the gene encoding the chromatin re-
modelling protein Myst4 (Ura et al, 2011) as well as the
cell-surface markers Ncam and Itga9 (Rugg-Gunn et al,
2012). In addition, Oct4, which does not contain the
Nanog/Sox2 motif, did not change expression level in
absence of a Nanog/Sox2 functional complex. It is therefore
likely that the effect of disrupting the Nanog/Sox2 complex
on self-renewal is a consequence of the misregulation of the
genes controlled by the two proteins in complex.
Discussion
By taking advantage of improved methodology (van den Berg
et al, 2010) the Nanog interactome has been expanded to over
130 proteins which can be subdivided into a number of
different categories (Table I; Supplementary Table I). Many
Figure 4 The serine-rich domain of Sox2 interacts with Nanog. (A) Top, schematic representation of the (FLAG)3Sox2 constructs. Bottom,
(HA)3Nanog and the indicated (FLAG)3Sox2 deletion mutants were transfected into E14/T cells and immunoprecipitations were performed
with an HA antibody as indicated and immunoblots probed with anti-FLAG or anti-HA antibodies. I is 1% of input. (B) Left, schematic
representation of the (FLAG)3Sox2 and (HA)3Nanog constructs used to assess the DNA independence of the Nanog–Sox2 interaction. Right,
E14/T cells were transfected with the indicated vectors. Immunoprecipitations were performed with an HA antibody as indicated and
immunoblots probed with anti-FLAG or anti-HA antibodies. I is 1% of input. Source data for this ﬁgure is available on the online
supplementary information page.
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of the proteins identiﬁed in the interactome are components of
large multi subunit complexes involved in chromatin modiﬁca-
tion, for several of which, all the known subunits are detected.
Most of these are considered to be transcriptional repressors
(NuRD, Polycomb Group protein (PcG), the atypical Polycomb
complex E2F6, Sin3a and N-CoR) that bind to genomic sites
adjacent to differentiation-speciﬁc genes to mediate repression
(Jepsen and Rosenfeld, 2002; McDonel et al, 2009; Surface
et al, 2010; Qin et al, 2012). Emerging evidence suggests that
NuRD and PcG complexes are also found at sites that are
actively transcribed (Brookes et al, 2012; Reynolds et al, 2012).
How the NuRD complex is directed to target genes is not fully
understood but Nanog and/or other NuRD-interacting
transcription factors may target the complex to the relevant
sites in the genome. In this respect, it is interesting that
inducing Nanog protein results in enhanced binding of both
Nanog and NuRD to the Nanog enhancer (Fidalgo et al, 2012).
Another proposed role for the chromatin modiﬁcation
complexes is to maintain repressed genes in a state that
allows a rapid response to external cues. Evidence for this
comes from the co-localization of enzymatically active PRC
complexes and the paused form of RNA PolII at a large
number of developmentally important genes (Brookes et al,
2012). This could allow alterations in the signalling
environment to promptly increase the level of gene
expression. The interaction of Nanog with both PRC and
RNA PolII may reﬂect this poised state of some genes. The
association with the chromatin modiﬁcation machinery is
common to transcription factors involved in maintenance of
ES cell pluripotency (Wang et al, 2006; Liang et al, 2008;
Pardo et al, 2010; van den Berg et al, 2010; Ding et al, 2012).
However, the range of complexes binding to individual
factors differs with SWI/SNF not directly connecting to
Nanog (this study; Wang et al, 2006) but interacting with
other transcription factors (van den Berg et al, 2010). Recent
data showing that Esrrb can substitute for Nanog function in
ES cells (Festuccia et al, 2012) could in part be explained by
the fact that Esrrb and Nanog bind to a number of the same
chromatin modiﬁcation complexes.
The Nanog interactome includes a number of proteins that
have not previously been identiﬁed in an ES cell transcription
factor interactome. In addition to TET-1, which has also been
shown to interact with Nanog (Costa et al, 2013), these
include the RNA processing proteins Ilf3, Rbm9, Pum1/2
and the transcription factors Zfp326, Arid5b, Zfp609.
Examining the function of these molecules and the signi-
ﬁcance of their interaction with Nanog will provide further
detail on how the extensive protein interaction network
functions to control pluripotency.
In this study, we have focussed on the interaction between
Nanog and Sox2 because of the central role of these proteins
in the pluripotency gene regulatory network. Sox2 has been
shown to interact with another key pluripotency factor, Oct4
by interaction of side chains within the DNA binding domains
(Ambrosetti et al, 1997, 2000). In the case of Nanog and Sox2,
interaction occurs through sequences outwith the DNA
binding domains. Nevertheless, the sequence of the SELEX
motif suggests that this interaction results in a speciﬁc spatial
relationship of DNA binding domains of both proteins on
DNA. The sequence of Sox2 that mediates interaction with
Nanog is a triple repeat of the sequence S X S/T Y.
Experiments analysing Sox2 mutants for their ability to
rescue ES cells from differentiation induced by Sox2
deletion demonstrate the importance of the interaction of
Nanog with Sox2. Mutation of the tyrosines in the S X S/T Y
motifs to alanines reduces the formation of undifferentiated
Figure 5 A subregion of the Sox2 serine-rich domain interacts with Nanog. (A) Schematic representation of the (FLAG)3Sox2 constructs used
for mapping the minimal Sox2 region involved in the interaction with Nanog. (B) E14/T cells were transfected with (HA)3Nanog and the
indicated (FLAG)3Sox2 mutants. Immunoprecipitations were performed with an HA antibody as indicated and immunoblots probed with an
anti-FLAG or anti-HA antibodies. I is 1% of input. Source data for this ﬁgure is available on the online supplementary information page.
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ES cell colonies to 50% of the level achieved using a non-
mutant Sox2 cDNA in the absence of any difference in protein
levels expressed by the transgene. Therefore, the 50% drop in
undifferentiated colonies observed in the presence of
Sox2:YYY4A is a result of the misregulation of Nanog/Sox2
gene targets. The use of the SELEX motif identiﬁed as a
Nanog/Sox2 target sequence together with a previously
published de novo target sequence (Hutchins et al, 2013)
allowed potential target genes of the Nanog/Sox2 complex
to be identiﬁed. A number of these genes show altered
expression upon abrogation of the Nanog/Sox2 interaction
(e.g., Ncam, Itga9, Klf5 and Myst4). However, not all the
genes tested are sensitive to loss of the interaction between
Nanog and Sox2 (Supplementary Table II). This could suggest
that in such cases the hydrophobic interaction of Nanog and
Sox2 proteins is not required for chromatin binding, or that
only in some cases is the associated gene sensitive to disrup-
tion of the interaction. The latter is reminiscent of our ﬁnding
that only a subset of loci that bind Nanog respond to the
presence of Nanog by modulating expression of a nearby
gene (Festuccia et al, 2012).
In ES cells, composite Oct/Sox binding sites have been
proposed to be redundantly regulated by Sox4, Sox11 and
Sox15 (Masui et al, 2007). However, this redundancy does not
extend to blockade of differentiation caused by Sox2 deletion.
Consistent with this, Sox4, Sox11 and Sox15 are not present
in the Nanog interactome and none of these Sox proteins
contains a sequence that matches the S X S/T Y motif.
The three copies of the S X S/T Y motif in Sox2 occur
within a 15-residue sequence in which 9 residues are hydro-
xyamino acids. Despite this preponderance of hydroxyamino
acids, it is the aromatic rings of the tyrosine residues that are
Figure 6 Identiﬁcation of amino-acid residues within Sox2(213–233) interacting with Nanog. (A) Top, schematic representation of hydroxyamino
acid mutations in repeats 1, 2 or 3 in Sox2. Bottom, E14/T cells were transfected with (HA)3Nanog and the indicated (FLAG)3Sox2 mutants.
Immunoblots of the HA immunoprecipitates were analysed by immunoblotting with an anti-FLAG or an anti-HA antibody. I is 1% of input.
(B) Top, schematic representation of the combinatorial mutations of the hydroxyamino acids in repeats 1, 2 and 3 of Sox2. Bottom, E14/Tcells
were transfected with (HA)3Nanog and the indicated (FLAG)3Sox2 mutants. Immunoblots of the HA immunoprecipitates were analysed by
immunoblotting with an anti-FLAG or an anti-HA antibody. I is 1% of input. (C) Top, schematic representation of the mutations of the
hydroxyamino acids in positions 1, 3 or 4 of repeats 1, 2 and 3 of Sox2. Bottom, E14/T cells were transfected with (HA)3Nanog and the
indicated (FLAG)3Sox2 mutants. Immunoblots of the HA immunoprecipitates were analysed by immunoblotting with an anti-FLAG or an anti-
HA antibody. I is 1% of input. (D) Top, schematic representation of the mutations of the hydroxyamino acids in position 4 of repeats 1, 2 and 3
of Sox2. Bottom, E14/T cells were transfected with (HA)3Nanog and the indicated (FLAG)3Sox2 mutants. Immunoblots of the HA
immunoprecipitates were analysed by immunoblotting with an anti-FLAG or an anti-HA antibody. I is 1% of input. Source data for this
ﬁgure is available on the online supplementary information page.
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critical mediators of the interaction with Nanog. This con-
clusion is derived from the fact that alanine substitution
of all three serines at position 1 of the repeats or all three
serines/threonines at position 3 of the repeats allowed
continued efﬁcient binding to Nanog, whereas alanine
substitution of all three tyrosines decreased the Nanog inter-
action severely. Moreover, the fact that the Nanog interaction
could be rescued when the tyrosines were substituted by
phenylalanines indicates that the tyrosine hydroxyl groups
are not required for the interaction and is highly suggestive
that the two proteins interact by stacking of the aro-
matic rings. This is consistent with the fact that tyrosine
and tryptophan residues cluster at protein–protein inter-
action ‘hot spots’ (Bogan and Thorn, 1998; DeLano,
2002). Functionally relevant stacking of tryptophan and
tyrosine residues has also been demonstrated in the
Figure 7 Identiﬁcation of a Nanog/Sox2 motif by SELEX. (A) Left, a Coomassie-stained SDS–PAGE gel of the imidazole eluate from the
Ni-agarose puriﬁcation of lysate from E. coli expressing His6-Nanog and Sox2, showing the major two bands identiﬁed as containing Nanog
(upper) and Sox2 (lower) by immunoblot analysis, as indicated on the right-hand panel. (B) Coomassie-stained SDS–PAGE gel of fractions from
ion-exchange puriﬁcation of Nanog/Sox2. Lanes 1–3 are protein from ﬂow-through fractions and lanes 4–7 are from the eluted peak.
(C) Sequence of 22 oligonucleotides that contribute to the motif generated by the de novo discovery program MEME. (D) Top panel, SELEX
motifs generated for Nanog and Sox2 expressed individually from a total of 19 (Nanog) and 15 (Sox2) sequences submitted to MEME; middle
panel, SELEX motif generated for Nanog/Sox2 complex from 38 sequences submitted to MEME; bottom panel, representation of the de novo
Nanog/Sox2 motif (Hutchins et al, 2013) and the combined motif from SELEX sequence for Nanog/Sox2 and de novo Nanog/Sox2 motif. Motifs
in the bottom panels were generated with Web Logo 3.3. (E) Nanog and Sox2 ChIP-seq peaks located near the transcriptional start sites of
Zfp42, Klf5, Ncam1 and Myst4. The peaks that contain the Nanog/Sox2 motif are highlighted in the shaded box; Nanog (N) and Sox2 (S) peaks
in data sets from Chen (C), Marson (M) and Whyte (W) data sets. Source data for this ﬁgure is available on the online supplementary
information page.
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formation of an aromatic gate in apo ﬂavodoxin (Genzor
et al, 1996), in the regulation of galactose oxidase activity
(Rogers et al, 2007) and, of particular relevance to this study,
in the interlocking of tyrosine and tryptophan residues at the
interaction interface of human nuclear receptor pregnane X
receptor (PXR) that mediates protein homodimerization
(Noble et al, 2006).
The lack of a requirement for the hydroxyl groups on Sox2
for the Nanog interaction is underscored by experiments using
bacterially expressed recombinant proteins that demonstrate
that the Nanog–Sox2 interaction occurs in the absence of post-
translational modiﬁcations. However, this does not mean that
post-translational modiﬁcations might not affect the interac-
tion between Nanog and Sox2. The interaction between the
Figure 8 The aromatic tyrosine side chains of the Nanog-interaction domain are required to fully rescue differentiation of Sox2 null ES cells. (A)
Scheme of the Sox2 conditional knock-out (Sox2CKO) cell line. (B) Top, alkaline phosphatase staining of the Sox2 null rescued cells. Sox2CKO
was transfected with the indicated vectors, selected in hygromycin and cultured in the presence or absence of tamoxifen. Cells were grown at
clonal density for 7 days before staining. Bottom, two representative ﬁelds of colonies obtained for the indicated treatments. (C) Quantiﬁcation
of the data from B. The number of alkaline phosphatase-positive colonies formed following transfection with the indicated vector was calculated
as a proportion of the number obtained by transfection with (Flag)3Sox2, which was set as 100%. Error bars, s.e.m. of at least four independent
experiments. ***Differences between FSox2 and FSox2:YYY4A by Mann–Whitney test (Po0.001). (D) Expression level of Flag-Sox2 variants in
clonal assay. Comparison of Sox2 expression in E14Tg2a (WT) with Sox2 CKO populations expressing eGFP, Flag-Sox2, FlagSox2:YYY4A,
FlagSox2:YYY4F, plated at clonal density for 7 days. (E) Expression levels of Nanog/Sox2 target genes. Expression levels of Rex1, Myst4, Ncam,
Itga9, Klf5 and Oct4 in cells plated at clonal density, treated with tamoxifen for 12h and grown for 7 days before RNA extraction. The expression
level in Sox2CKO F-Sox2 þ tamoxifen was set to 1. Error bars, s.e.m. of three biological replicates. *Differences between FSox2 and
FSox2:YYY4A by two-tailed t-test (Po0.05). Source data for this ﬁgure is available on the online supplementary information page.
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two proteins occurs through polypeptide stretches devoid of
strongly charged amino-acid side chains. Potential modiﬁca-
tion of hydroxyl groups on the Sox2 interaction surface,
whether on the tyrosine or on the neighbouring serine and
threonine residues, would introduce charged moieties that
would be expected to interfere with the interaction between
the hydrophobic interacting residues. Moreover, recent work
indicates that hydroxyl groups on Sox2 can also be modiﬁed
by addition of N-acetylglucosamine, although the effect on
Sox2 function is unclear (Jang et al, 2012). The fact that
Nanog interacts with proteins that mediate post-translational
modiﬁcations such as phosphorylation and ubiquitination is
consistent with the observation that Nanog is phosphorylated
(Yates and Chambers, 2005; Moretto-Zita et al, 2010) and
ubiquitinated (Moretto-Zita et al, 2010). In addition, Nanog
partners could also be affected by such modiﬁcations because
of physical proximity to the relevant enzymes. The role for
these modiﬁcations and how they inﬂuence interactions
between transcription factors and/or transcription factor
function in ES cells is an important area for future
investigation.
The high number of Nanog-interacting proteins identiﬁed in
this study suggest that Nanog acts as a ‘hub’ protein (Han
et al, 2004; Mullin and Chambers, 2012). The ability of
individual partner proteins to interact with a hub protein
like Nanog depends on the afﬁnity of the interaction and the
availability of the binding sites on both the hub protein and
the partner, as has been discussed previously (Han et al, 2004;
Mullin and Chambers, 2012). Since both competitive and non-
competitive interactions are simultaneously possible, it will be
important to determine which factors compete for the same
regions of Nanog. Of particular relevance will be whether
factors that bind through the WR interact through a precise
subregion of the WR or if there is variability in the exact
sequence bound by a speciﬁc partner. To date, only Sox2 and
Nac1 have been demonstrated to interact directly with the
WR. Loss of the tryptophans of the WR has also been
demonstrated to abrogate the interaction of Nanog with
Sall4, Nr0b1, Zfp198 and Zfp281 (Wang et al, 2008) but a
direct interaction has not yet been shown for these proteins. In
the situation where multiple factors bind the WR it is possible
that binding of one factor could increase the afﬁnity of another
protein for interaction with an adjacent site in the same region
resulting in co-operative binding of two or more factors. A
clear potential example of this could be Nac-1, which has been
reported to bind the C-terminal WR subunit (Ma et al, 2009). It
is possible that both competitive and non-competitive binding
to distinct sites on Nanog occurs simultaneously, allowing
the assembly of large, functionally active complexes. An
additional level of complexity arises from the possibility that
the Nanog/Sox2 interaction may occur with either monomeric
or dimeric Nanog (Mullin et al, 2008; Wang et al, 2008).
Potential mechanisms that affect the Nanog dimerization equi-
librium, such as covalent modiﬁcations, could thereby play an
important part in regulating interactions and subsequent
downstream events.
Materials and methods
ES cell culture
Mouse ESC lines were cultured on gelatin-coated dishes without
feeders in GMEM/b-mercaptoethanol/10% FCS/LIF (GMEMb/FCS/
LIF) as described (Smith, 1991). Nanog null RCNbH-B(t) cells have
been described (Chambers et al, 2007): brieﬂy, these cells have an
IRES-HygromycinR-pA or an IRES-bgeo-pA replacement of Nanog
sequences from intron I through to the 3’UTR. Sox2 conditional
knock-out cells were obtained by re-targeting ES cells heterozygous
for a Sox2ﬂox allele (Favaro et al, 2009) with a Sox2-b-geo ‘knock-in’
targeting vector (Zappone et al, 2000; Avilion et al, 2003). This was
followed by stable transfection of a pPyCAG-CreERT2IP construct
(Figure 8A). Puromycin-resistant clones were screened for efﬁcient
deletion of the Sox2ﬂox allele following tamoxifen treatment to select
the Sox2CKO clone used here.
E14Tg2a (Flag)3-Nanog and RCNbH-B(t) (Flag)3-Nanog cells were
generated by electroporating E14Tg2a (Hooper et al, 1987) and
RCNbH-B(t) cells with pPyCAG (Flag)3NanogIP (Mullin et al, 2008)
linearized with ScaI. Electroporated cells were plated in GMEMb/
FCS/LIF and after 30 h, 1 mg/ml puromycin (Sigma, P9620) was
added. Medium was replaced every 2 days and after 12 days,
puromycin-resistant colonies were picked and Nanog expression
levels were determined by immunoblotting with a-Nanog antibody
(Chambers et al, 2007). Sox2CKO cells expressing (Flag)3-Sox2,
(Flag)3-Sox2:YYY4A, (Flag)3-Sox2: YYY4F or eGFP control were
generated by electroporating Sox2CKO cells with pPyCAG(Flag)3-
Sox2IH, pPyCAG(Flag)3-Sox2:YYY4AIH or pPyCAG(Flag)3-Sox2:
YYY4FIH linearized with FspI. Electroporated cells were plated in
GMEMb/FCS/LIF medium and after 30h, 100mg/ml hygromycin B
(Roche, 10843555001) was added. Medium was replaced every 2
days and after 12 days, hygromycin-resistant colonies were pooled
to generate populations for rescue assays.
Colony-forming assays were as described (Chambers et al, 2003).
Plasmids
(HA)3-Nanog, (HA)3-NanogDN, (HA)3-NanogDHD, (HA)3-NanogDC,
(HA)3-NanogDC49 and (HA)3-NanogDWR have been described
(Mullin et al, 2008). (HA)3-NanogWRW10A was generated by
inserting synthetic DNA in which all 10 tryptophan codons were
replaced by alanine codons between the two SexAI sites in the
Nanog ORF. Flag-Sox2 was generated by cloning a Sox2 PCR
product between the BamHI and NotI sites of pPyCAG(FLAG)3IP.
(Flag)3-Sox2 1-263, (Flag)3-Sox2 1-204, (Flag)3-Sox2 1-233, (Flag)3-
Sox2 1-226, (Flag)3-Sox2 1-218 and (Flag)3-Sox2 1-212 were
generated by PCR using a forward primer containing a XhoI site 50
to the (Flag)3 tag and reverse primers containing a stop codon at the
desired position followed by a NotI site. (Flag)3-Sox2 DHMG and
(Flag)3-Sox2 D205–233 were generated by PCR by overlap extension
(Ho et al, 1989). PCR products were cloned between the XhoI and
NotI sites in pPyCAGIP. (Flag)3-Sox2 DN120 was generated by PCR
using a forward bipartite primer, containing a BamHI site, which
anneals to the linker between the (Flag)3 tag and the Sox2 sequence
and a sequence starting at codon 121 and a reverse primer
containing a NotI site after the Sox2 stop codon. The PCR product
was cloned between the BamHI and the NotI sites in
pPyCAGIP(Flag)3-Sox2 vector. The primers used for the above
PCRs are listed in Supplementary Table III.
(Flag)3-Sox2:Rep14A, (Flag)3-Sox2:Rep24A, (Flag)3-Sox2:
Rep34A, (Flag)3-Sox2:Rep1þ 24A, (Flag)3-Sox2:Rep1þ 34A,
(Flag)3-Sox2:Rep2þ 34A, (Flag)3-Sox2:Rep1þ 2þ 34A, (Flag)3-
Sox2:SSS4A, (Flag)3-Sox2:TTS4A, (Flag)3-Sox2:YYY4A and
(Flag)3-Sox2:YYY4F were generated by introducing synthetic DNA
encoding the desired sequences (Genscript) between AgeI and ClaI
sites in the Sox2 ORF. These two sites were introduced into Sox2 by
silent mutation of C(693)4G (AgeI) and C(810)4A, C(813)4G
(ClaI) (NM_011443.3). The coding sequence of all plasmids gener-
ated was checked by sequencing for absence of unwanted mutations.
Rescue experiments
Sox2CKO cell lines, stably expressing (Flag)3-Sox2, (Flag)3-
Sox2:YYY4A, (Flag)3-Sox2:YYY4F or eGFP were preselected for
3–5 days with 200mg/ml G418 (PAA, P31-011), 0.75mg/ml puromycin
and 100mg/ml hygromycin B. Cells were plated at clonal density
(3103 cells/63 cm2 dish) in hygromycin B (100mg/ml) for 24h. 4-
OH Tamoxifen (1mM) (Sigma, H7904) was added (12h) to delete the
endogenous Sox2 allele. Cells were cultured in 100mg/ml hygromy-
cin B for 14 days before alkaline phosphatase staining (Sigma, 86R).
The rescue efﬁciency was determined from the ratio of alkaline-
positive ES cell colonies (plus Tamoxifen/minus Tamoxifen).
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Protein puriﬁcation
Preparation of nuclear extracts and puriﬁcation of Flag-tagged pro-
teins were performed as described (van den Berg et al, 2010). Brieﬂy,
nuclear extract was prepared from cells (Dignam et al, 1983) and
Flag-tagged protein puriﬁed using 60ml Flag-agarose beads per 1.5ml
of nuclear extract, during which samples were treated with 150U/ml
DNase Benzonase (41C, 3 h) to decrease spurious protein puriﬁcation
due to DNA bridging. Nanog and interacting proteins were then
eluted using Flag peptide (0.2mg/ml). For production of proteins in
E. coli MBP-WR/Sox2 and MBP-WRW104A/Sox2 were cloned into
pET Duet (Novagen) and expressed in BL21(DE3) cells. MBP-tagged
proteins were lysed in 10mM Tris pH 8.0, 100mM NaCl, passed over
amylose resin (NEB, E8021S), washed and proteins eluted with
10mM maltose. Co-purifying protein was detected by immuno-
blotting. For SELEX, Nanog was cloned into pMalc2e (NEB) in
frame with MBP and expressed in BL21 cells by addition of 1mM
IPTG. Cells were lysed in 10mM Tris pH 8.0, 200mM NaCl and
puriﬁed on amylose resin. Sox2 was cloned into pET15b (Novagen)
and expressed in BL21(DE3) by addition of 1mM IPTG. Protein
was puriﬁed by lysing cells in 25mM Tris pH 8.0, 30mM
imidazole, 500mM NaCl and passing lysate over nickel resin
(His-select, Sigma, P6611). For co-expression, Nanog and Sox2
were cloned into pET Duet, to encode (His)6-Nanog and un-
modiﬁed Sox2 and expressed in BL21(DE3) cells induced with
1mM IPTG. Cells were lysed in 25mM Hepes pH 7.6, 1M NaCl,
5mM imidazole and lysate incubated in batch mode with nickel
resin. Ion-exchange puriﬁcation of Nanog/Sox2 was performed at pH
7.6 on a 1-ml CM Sepharose FF column (GE Healthcare, 17-5056-01).
Bound protein was eluted using a gradient of 0–1M NaCl over 20
column volumes.
Co-immunoprecipitations
For validation of Nanog interactors from E14Tg2a F-Nanog, 5mg of
Flag antibody (Sigma, F3165) or mouse IgG control (Santa Cruz, sc-
2015) was added to 200ml of nuclear extract and incubated (41C,
3 h). Immunocomplexes were puriﬁed by addition of Protein G,
washed in 20mM Hepes pH 7.6, 10% glycerol, 100mM KCl, 1.5mM
MgCl2, 0.2mM EDTA pH 8, 0.2% NP-40, 0.5mM DTTand eluted in
Laemmli buffer (Laemmli, 1970). For probing extracts from RCNbH-
B(t) and RCNbH-B(t) (Flag)3-Nanog, FLAG agarose (Sigma, A2220)
was used to purify proteins. Complexes were eluted in Laemmli
buffer and analysed by immunoblotting.
For the characterization of the Nanog–Sox2 interaction, E14/T
cells were transfected using Lipofectamine 2000 (Invitrogen, 11668-
019) with (HA)3-Nanog or Nanog mutants and (Flag)3Sox2 or Sox2
mutants and nuclear extract was prepared. In all, 5mg of HA
antibody (MMS-101P, Covance) was added (41C, 3 h) and immuno-
complexes puriﬁed as above. Immunocomplexes were fractionated
on NuPage-Novex 10% Bis-Tris gels (Invitrogen, NP0301BOX) and
co-immunoprecipitating proteins detected by immunoblotting using
the following antibodies: a-Sall4 (gift of Matthias Treir), a-Mta2
(8106, Abcam), a-Sox2 (sc-17320, Santa Cruz), a-Nanog (A300-
397A, Bethyl Laboratories), a-Nac-1 (29047, Abcam), a-RNAPolII
(PB-7C2, Euromedex) and a-Flag antibody (Sigma, F3165).
Immunoblots
Cells were lysed in 20mM Hepes pH 7.6, 20% glycerol, 250mM KCl,
1.5mM MgCl2, 0.2mM EDTA, 0.5mM DTT, 0.5% NP-40 and 1
protease inhibitor cocktail (Roche). Protein extract was treated with
150U/ml DNase Benzonase (Novagen) (30min, 41C), 60 mg of
lysate run on SDS–PAGE (Laemmli, 1970), transferred onto
nitrocellulose (Whatman(R) Protran(R)) and blots probed with
antibodies diluted in 5% non-fat dry milk/TBS/0.01% Tween-20.
Membranes were developed with Super-Signal West Pico (Pierce)
and exposed to Hyperﬁlm (Amersham). Primary antibodies were
anti-Nanog (Chambers et al, 2007), 0.5 mg/ml, anti-Sox2 (sc-17320,
Santa Cruz) 0.2mg/ml and anti-LaminB (sc-6216, cs-6217 Santa
Cruz) 0.2 mg/ml.
Protein interaction network criteria
Criteria for inclusion in Table I and Supplementary Table I as a
Nanog-interacting protein are present in two out of the three
puriﬁcations from E14Tg2a:F-Nanog and RCNbH-B(t):F-Nanog
cells, with a Mascot score of 450 and at least three-fold higher
than in the corresponding control experiment. The Mascot score is a
statistical measure of conﬁdence of correct identiﬁcation of a
protein from its peptides (Perkins et al, 1999).
SELEX
Recombinant proteins used in SELEX assays were puriﬁed as
described above. Puriﬁed protein identities were established by
N-terminal sequencing (performed at the LIGHT Laboratories,
Faculty of Biological Sciences, Leeds University by Edman degrada-
tion). Resin was washed with puriﬁcation buffer supplemented
with imidazole to 50mM and used directly in SELEX. The oligo
library contained 25 bp of random sequence ﬂanked by ACGTG
GATCCACTGACGG and GCTAGCGCCTCGAGACTTG. The double
stranded library was synthesized by annealing the single-stranded
library to a reverse primer and incubating in a Klenow fragment
reaction. The initial round of SELEX consisted of incubation of
10 pmol of protein (on bead) with 20pmol library in 20mM
Hepes pH 7.6, 200mM KCl, 10% glycerol for 1 h. After extensive
washing, bound oligonucleotides were eluted with imidazole
containing buffer. PCR ampliﬁcation of bound oligonucleotide
was performed and the enrichment cycle repeated with 300 ng
of total DNA. Five enrichment rounds were performed after
which PCR products were cloned into TopoTA (Invitrogen).
Individual clones were picked, DNA prepared and sequenced.
Obtained sequences were submitted to MEME for motif searching
(Bailey et al, 2009).
Combined ChIP-seq and motif analysis
To identify joint Nanog–Sox2 (NS) DNA-binding events, enriched
binding events (‘peaks’) based on three ChIP-seq experiments
(Marson et al, 2008; Chen et al, 2008b; Whyte et al, 2013) were
combined using GeneProf (http://www.geneprof.org; Halbritter
et al, 2012). After centring peaks on ±50 bp surrounding the
highest point in the alignment, those overlapping in at least 1 bp
were taken forward as joint NS peaks. A regular expression
(A[TGA]T..[TC][AT]TT[GCT][AT]) was used to ﬁnd occurrences
of the NS motif. Peaks were linked to the closest transcription
start site (max. distancep30kb). The full analysis workﬂow is
accessible at gpXP_001309 (http://www.geneprof.org/show?id=
gpXP_001309).
Quantitative PCR
RNA was extracted with TRIZOL (Invitrogen), DNase treated
(Qiagen) and reverse transcribed with SuperScriptIII (Invitrogen).
(Q)PCRs were performed in 384-well plates with a 480 LightCycler
(Roche) using LightCycler 480 SYBR Green I Master (Roche). All
primer sequences are listed in Supplementary Table III.
Supplementary data
Supplementary data are available at The EMBO Journal Online
(http://www.embojournal.org).
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